+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Delpor Inc - logo

Delpor company enables the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant device. They use 3 different technologies: Prozor, Nanopor, and Delos Pump. Delpor was founded in 2009, its headquarters is situated in San Francisco, California. Delpors DLP-114 is a 3-6 month formulation of Risperidone. This product is using Delpors Prozor technology It is expected to maintain therapeutic levels of Risperidone and its active metabolite in human plasma.

From
From
From
From
Implantable Drug Delivery Devices Global Market Report 2024 - Product Thumbnail Image

Implantable Drug Delivery Devices Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
From
From
From
From
From
Opium (Opioid) Addiction - Pipeline Review, H2 2020 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 193 Pages
  • Global
From
From
D Antagonist - Pipeline Insight, 2022 - Product Thumbnail Image

D Antagonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 90 Pages
  • Global
From
Loading Indicator